← back to search

Matthias Hebrok

University of California, San Francisco · US
Area of research
Surgery · Oncology
Research interest
Research interests include Pancreatic function and diabetes, Pancreatic and Hepatic Oncology Research, Diabetes and associated disorders, and Diabetes Management and Research.
h-index
76
citations
20,181
works
240
NIH funding
primary concept
email

Recent publications

Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs
Science 2024cited by 47position: middledoi
Sox9 regulates alternative splicing and pancreatic beta cell function
Nature Communications 2024cited by 18position: lastdoi
Species-specific roles for the MAFA and MAFB transcription factors in regulating islet β cell identity
JCI Insight 2023cited by 9position: middledoi
Stem Cell-Based Clinical Trials for Diabetes Mellitus
Frontiers in Endocrinology 2021cited by 135position: lastdoi
Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection
Cell Reports 2021cited by 83position: lastdoi
Mutations and variants of ONECUT1 in diabetes
Nature Medicine 2021cited by 57position: middledoi
Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree
eLife 2021cited by 48position: lastdoi
Emerging routes to the generation of functional β-cells for diabetes mellitus cell therapy
Nature Reviews Endocrinology 2020cited by 128position: lastdoi
Loss of the transcription factor MAFB limits β-cell derivation from human PSCs
Nature Communications 2020cited by 58position: lastdoi
Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived β cells
Nature Cell Biology 2019cited by 488position: lastdoi
mTORC1-to-AMPK switching underlies β cell metabolic plasticity during maturation and diabetes
Journal of Clinical Investigation 2019cited by 125position: middledoi
Lipid Droplet Accumulation in Human Pancreatic Islets Is Dependent On Both Donor Age and Health
Diabetes 2019cited by 67position: middledoi
Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges
Cell stem cell 2018cited by 250position: lastdoi
Replication confers β cell immaturity
Nature Communications 2018cited by 157position: lastdoi
The BRG1/SOX9 axis is critical for acinar cell–derived pancreatic tumorigenesis
Journal of Clinical Investigation 2018cited by 57position: middledoi
Mitigating Ischemic Injury of Stem Cell-Derived Insulin-Producing Cells after Transplant
Stem Cell Reports 2017cited by 62position: middledoi
Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression
Nature Medicine 2016cited by 596position: middledoi
Human islets contain four distinct subtypes of β cells
Nature Communications 2016cited by 379position: middledoi
Human pancreatic beta-like cells converted from fibroblasts
Nature Communications 2016cited by 160position: middledoi
Life and death of β cells in Type 1 diabetes: A comprehensive review
Journal of Autoimmunity 2016cited by 100position: middledoi
Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity
Diabetologia 2016cited by 32position: middledoi
Controlled induction of human pancreatic progenitors produces functional beta‐like cells <i>in vitro</i>
The EMBO Journal 2015cited by 581position: lastdoi
DNA methylation directs functional maturation of pancreatic β cells
Journal of Clinical Investigation 2015cited by 157position: middledoi
Islet formation in mice and men: lessons for the generation of functional insulin-producing β-cells from human pluripotent stem cells
Current Opinion in Genetics & Development 2015cited by 116position: lastdoi
NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar–Ductal Transdifferentiation in the Pancreas
Gastroenterology 2015cited by 103position: middledoi
Regulation of Cellular Identity in Cancer
Developmental Cell 2015cited by 93position: lastdoi
β-Cell Insulin Secretion Requires the Ubiquitin Ligase COP1
Cell 2015cited by 81position: middledoi
Human stem cells from single blastomeres reveal pathways of Embryonic or trophoblast fate specification
Development 2015cited by 71position: middledoi
CDK1 Inhibition Targets the p53-NOXA-MCL1 Axis, Selectively Kills Embryonic Stem Cells, and Prevents Teratoma Formation
Stem Cell Reports 2015cited by 65position: middledoi
The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma
Nature Cell Biology 2014cited by 188position: lastdoi

Grants

Collaborative Research: Bioprocess development for the generation of functional pancreatic islet cells from human pluripotent stem cells
NSF1743407$472,4012017–2021PIRePORTER

Frequent collaborators

Holger A. Russ · University of Florida12 papers (2013–2024)Gopika G. Nair · Eli Lilly (United States)7 papers (2015–2024)John P. Morris · UNC Lineberger Comprehensive Cancer Center6 papers (2012–2014)Sapna Puri · Government Medical College5 papers (2014–2024)Audrey V. Parent · University of California, San Francisco5 papers (2013–2024)Tingxia Guo · Fate Therapeutics (United States)4 papers (2013–2015)Simone Giacometti · University of California, San Francisco4 papers (2019–2021)Nilotpal Roy · Symbiosis International University4 papers (2014–2018)Guido von Figura · TUM Klinikum4 papers (2012–2014)Grace Kim · Illumina (United States)4 papers (2014–2021)Anil Bhushan · University of California, San Francisco3 papers (2015–2019)Qizhi Tang · Broad Center3 papers (2017–2021)Gregory L. Szot · University of California, San Francisco3 papers (2015–2019) · 3 papers (2019–2023)Gaetano Faleo · Gladstone Institutes2 papers (2017–2021)Michael S. Saxton · University of California, San Francisco2 papers (2019–2021)Grace Wei · Nanjing Second Hospital2 papers (2012–2015)Yuval Dor · Ludwig-Maximilians-Universität München2 papers (2019–2023)Xin Tong · Indiana University School of Medicine2 papers (2019–2023)Tao Xu · Bengbu Medical College2 papers (2014–2016)